400
Participants
Start Date
July 10, 2023
Primary Completion Date
April 18, 2024
Study Completion Date
April 18, 2024
Research Site, Belo Horizonte
Research Site, Porto Alegre
Research Site, Recife
Research Site, Salvador
Research Site, São Paulo
Lead Sponsor
Hospital Israelita Albert Einstein
OTHER
AstraZeneca
INDUSTRY